AbelsonTaylor Promotes Katerina Steele to Associate Director, Business Development and Analysis

Chicago, April 12, 2016 – Determination, drive and expertise in data analysis have led to the promotion of Katerina Steele to associate director of business development and analysis at AbelsonTaylor, the largest independent medical agency-of-record company in the world. She was previously manager of new business development.

“Katerina has been instrumental in the creation and growth of our agency’s business development group,” said Jay Carter, senior VP, and director of strategy services. “Her initiative and collaborative spirit have made her the acknowledged point person in our entire pitch process, making her a tremendous asset to both our clients and our agency.”

Steele, who joined AbelsonTaylor in 2004, understood the critical role new business plays in agency growth. She transitioned into the business development group in 2008 after a strong track record of performance in various roles and responsibilities at the agency.

Under her leadership and guidance, she formalized and operationalized the process for responding to Requests for Proposal (RFPs) and is also credited with building greater efficiencies in pitch execution and analyses of disease state markets. What began as a one-member department has turned into a nimble group of dynamic staff members who she now guides and mentors.

A graduate of the University of Chicago. Steele holds a Bachelor of Arts degree in music theory and composition. She is expected to receive her MBA, with concentrations in marketing, econometrics & statistics and operations management, from the University of Chicago Booth School of Business later this year.

She currently lives in Chicago, Ill.

About AbelsonTaylor

AbelsonTaylor is the largest independent medical agency-of-record company in the world. Established in 1981, AbelsonTaylor serves pharmaceutical, biotech and health-and-wellness companies, creating award-winning brand experiences in broadcast, print and digital. To learn more, visit abelsontaylor.com and follow the company on Twitter and Facebook.